Long-term administration of GnRH agonists is thought to reduce inflammation caused by endometriosis, thereby improving oocyte quality, and restoring endometrial receptivity [30]. However, our study found no significant differences in biochemical, clinical, and ongoing pregnancies between ultra-long and short protocols used in the endometriosis group. This evidence concerns the gene GNRH1 and endometriosis.